Dengue Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1055324
  • May 2021
  • Pharmaceuticals
  • 124 Pages
The need for worldwide dengue vaccines marketplace is anticipated to enrich throughout the coming decades, due to the growing occurrence of dengue temperature, developing amount of federal government projects, unexpected and uncontrolled urbanization, not enough standard features in forums, and bad control this is certainly ecological. Furthermore, facets such as for instance populace development, globalisation and tourist, and weather change encourages sign that will be increasing of anticipating in boosting need of dengue vaccines. Aspects impeding the need of dengue vaccines were insufficient cycle that will be cooler for storage space of vaccine, standardised diagnostics apply, shortage of right monitoring program and regulating difficulties in vaccines arrangements. Apex Market Research, within the coming document entitled, “Global Dengue Vaccines marketplace fashions, solutions, testing, progress, and anticipate: 2018 to 2027”, provides detailed knowledge, profits facts, and various other ideas that will be essential the dengue vaccines industry additionally the different fashions, vehicle operators, restraints, potential, and risks when you look at the target audience till 2027. The document has the benefit of informative and suggestions that will be intricate the different trick participants functioning when you look at the international dengue vaccines marketplace, as well as their financials, aside from tricks, purchases mergers, and marketplace impact. The dengue that will be international marketplace happens to be segmented based on tech, submission station, and area. The dengue this is certainly worldwide marketplace is estimated to enhance at a CAGR of X.Xper cent from 2018 to 2027, and is also anticipated to achieve US$XXX million towards the end of 2027. The dengue this is certainly international markets document is segmented based on development, submission route and area. Presently in Asia pacific region like Brazil, Mexico, Thailand, Singapore and India because of urbanization this is certainly fast restricted usage of fundamental providers, and weather modification are markets frontrunner for dengue vaccines. Medical facilities were most frequent and very income station this is certainly generating of.

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

The Dengue Vaccines market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Dengue Vaccines market research report recommends a business strategy for present market participants to strengthen their position in the market.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Dengue Vaccines market along with their effects over the forecast period. Similarly, according to the region Dengue Vaccines market research report includes the study of opportunities available in the market situation.

The Dengue Vaccines market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Dengue Vaccines Market:
The Dengue Vaccines market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Sanofi Pasteur Inc., Merck & Co., Inc., GlaxoSmithKline plc., Pfizer Inc., Panacea Biotec Limited, Instituto Butantan, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Limited, GeneOne Life Science Inc., Medigen Vaccine Biologics Corporation

Dengue Vaccines Market Segmentation Analysis:
Segmentation on the basis of technology:
Live attenuated vaccine
Chimeric Live attenuated vaccine
Subunit vaccine
Inactivated vaccine
Nucleic acid based vaccine
Segmentation on the basis of distribution channel:
Hospitals
NGO’s
Government Institutes
Pharmacy

Global Dengue Vaccines Market Segmentation by Regions:
In regional analysis, Dengue Vaccines market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Dengue Vaccines market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Dengue Vaccines Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Dengue Vaccines Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Dengue Vaccines Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Dengue Vaccines Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Dengue Vaccines Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Dengue Vaccines market, according to the key region.
  • To study the Dengue Vaccines market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Dengue Vaccines market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Dengue Vaccines research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Dengue Vaccines market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Dengue Vaccines market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Dengue Vaccines market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Dengue Vaccines market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Dengue Vaccines market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Sanofi Pasteur Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Panacea Biotec Limited
  • Instituto Butantan
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Limited
  • GeneOne Life Science Inc.
  • Medigen Vaccine Biologics Corporation
  • Live attenuated vaccine
  • Chimeric Live attenuated vaccine
  • Subunit vaccine
  • Inactivated vaccine
  • Nucleic acid based vaccine
  • Hospitals
  • NGO’s
  • Government Institutes
  • Pharmacy

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Dengue Vaccines Market Snapshot
          2.1.1. Global Dengue Vaccines Market By Type,2019
               2.1.1.1.Live attenuated vaccine
               2.1.1.2.Chimeric Live attenuated vaccine
               2.1.1.3.Subunit vaccine
               2.1.1.4.Inactivated vaccine
               2.1.1.5.Nucleic acid based vaccine
          2.1.2. Global Dengue Vaccines Market By Application,2019
               2.1.2.1.Hospitals
               2.1.2.2.NGO’s
               2.1.2.3.Government Institutes
               2.1.2.4.Pharmacy
          2.1.3. Global Dengue Vaccines Market By End-use,2019
          2.1.4. Global Dengue Vaccines Market By Geography,2019

3. Global Dengue Vaccines Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Dengue Vaccines Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Dengue Vaccines Market Size (US$), By Type, 2018 – 2028

5. Global Dengue Vaccines Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Dengue Vaccines Market Size (US$), By Application, 2018 – 2028

6. Global Dengue Vaccines Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Dengue Vaccines Market Size (US$), By End-use, 2018 – 2028

7. Global Dengue Vaccines Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Dengue Vaccines Market Analysis, 2018 – 2028 
          7.2.1. North America Dengue Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Dengue Vaccines Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Dengue Vaccines Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Dengue Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Dengue Vaccines Market Analysis, 2018 – 2028 
          7.3.1.  Europe Dengue Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Dengue Vaccines Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Dengue Vaccines Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Dengue Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Dengue Vaccines Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Dengue Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Dengue Vaccines Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Dengue Vaccines Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Dengue Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Dengue Vaccines Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Dengue Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Dengue Vaccines Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Dengue Vaccines Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Dengue Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Dengue Vaccines Market Analysis, 2018 – 2028 
          7.6.1.  MEA Dengue Vaccines Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Dengue Vaccines Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Dengue Vaccines Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Dengue Vaccines Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Dengue Vaccines Providers
        8.4.1 Sanofi Pasteur Inc.
                8.4.1.1 Business Description
                8.4.1.2 Sanofi Pasteur Inc. Geographic Operations
                8.4.1.3 Sanofi Pasteur Inc. Financial Information
                8.4.1.4 Sanofi Pasteur Inc. Product Positions/Portfolio
                8.4.1.5 Sanofi Pasteur Inc. Key Developments
        8.4.2 Merck & Co., Inc.
                8.4.2.1 Business Description
                8.4.2.2 Merck & Co., Inc. Geographic Operations
                8.4.2.3 Merck & Co., Inc. Financial Information
                8.4.2.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.2.5 Merck & Co., Inc. Key Developments
        8.4.3 GlaxoSmithKline plc.
                8.4.3.1 Business Description
                8.4.3.2 GlaxoSmithKline plc. Geographic Operations
                8.4.3.3 GlaxoSmithKline plc. Financial Information
                8.4.3.4 GlaxoSmithKline plc. Product Positions/Portfolio
                8.4.3.5 GlaxoSmithKline plc. Key Developments
        8.4.4 Pfizer Inc.
                8.4.4.1 Business Description
                8.4.4.2 Pfizer Inc. Geographic Operations
                8.4.4.3 Pfizer Inc. Financial Information
                8.4.4.4 Pfizer Inc. Product Positions/Portfolio
                8.4.4.5 Pfizer Inc. Key Developments
        8.4.5 Panacea Biotec Limited
                8.4.5.1 Business Description
                8.4.5.2 Panacea Biotec Limited Geographic Operations
                8.4.5.3 Panacea Biotec Limited Financial Information
                8.4.5.4 Panacea Biotec Limited Product Positions/Portfolio
                8.4.5.5 Panacea Biotec Limited Key Developments
        8.4.6 Instituto Butantan
                8.4.6.1 Business Description
                8.4.6.2 Instituto Butantan Geographic Operations
                8.4.6.3 Instituto Butantan Financial Information
                8.4.6.4 Instituto Butantan Product Positions/Portfolio
                8.4.6.5 Instituto Butantan Key Developments
        8.4.7 Takeda Pharmaceutical Company Limited
                8.4.7.1 Business Description
                8.4.7.2 Takeda Pharmaceutical Company Limited Geographic Operations
                8.4.7.3 Takeda Pharmaceutical Company Limited Financial Information
                8.4.7.4 Takeda Pharmaceutical Company Limited Product Positions/Portfolio
                8.4.7.5 Takeda Pharmaceutical Company Limited Key Developments
        8.4.8 Sun Pharmaceutical Industries Limited
                8.4.8.1 Business Description
                8.4.8.2 Sun Pharmaceutical Industries Limited Geographic Operations
                8.4.8.3 Sun Pharmaceutical Industries Limited Financial Information
                8.4.8.4 Sun Pharmaceutical Industries Limited Product Positions/Portfolio
                8.4.8.5 Sun Pharmaceutical Industries Limited Key Developments
        8.4.9 GeneOne Life Science Inc.
                8.4.9.1 Business Description
                8.4.9.2 GeneOne Life Science Inc. Geographic Operations
                8.4.9.3 GeneOne Life Science Inc. Financial Information
                8.4.9.4 GeneOne Life Science Inc. Product Positions/Portfolio
                8.4.9.5 GeneOne Life Science Inc. Key Developments
        8.4.10 Medigen Vaccine Biologics Corporation
                8.4.10.1 Business Description
                8.4.10.2 Medigen Vaccine Biologics Corporation Geographic Operations
                8.4.10.3 Medigen Vaccine Biologics Corporation Financial Information
                8.4.10.4 Medigen Vaccine Biologics Corporation Product Positions/Portfolio
                8.4.10.5 Medigen Vaccine Biologics Corporation Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Dengue Vaccines Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Dengue Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Dengue Vaccines Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Dengue Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Dengue Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Dengue Vaccines Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Dengue Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Dengue Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Dengue Vaccines Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Dengue Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Dengue Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Dengue Vaccines Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Dengue Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Dengue Vaccines Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Dengue Vaccines Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Dengue Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Dengue Vaccines: Market Segmentation 
FIG. 2 Global Dengue Vaccines Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Dengue Vaccines Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Dengue Vaccines Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Dengue Vaccines Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Dengue Vaccines Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Dengue Vaccines Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Dengue Vaccines Providers, 2019
FIG. 11 Global Dengue Vaccines Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Dengue Vaccines Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Dengue Vaccines Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Dengue Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Dengue Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Dengue Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Dengue Vaccines Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Dengue Vaccines Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Dengue Vaccines market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Dengue Vaccines Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Dengue Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  North America Dengue Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  North America Dengue Vaccines Market Value, By Country, 2018 – 2028
TABLE  Europe Dengue Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Europe Dengue Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Europe Dengue Vaccines Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Dengue Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Dengue Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Dengue Vaccines Market Value, By Country, 2018 – 2028
TABLE  Latin America Dengue Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Dengue Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Dengue Vaccines Market Value, By Country, 2018 – 2028
TABLE  MEA Dengue Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  MEA Dengue Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  MEA Dengue Vaccines Market Value, By Country, 2018 – 2028
TABLE  Sanofi Pasteur Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Panacea Biotec Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Instituto Butantan: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda Pharmaceutical Company Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sun Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GeneOne Life Science Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Medigen Vaccine Biologics Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Dengue Vaccines Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Dengue Vaccines Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Dengue Vaccines Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Dengue Vaccines Market, By Geography, 2019 (US$ Mn)
FIG.  Global Dengue Vaccines Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Dengue Vaccines Providers, 2016
FIG.  Global Dengue Vaccines Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Chimeric Live attenuated vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Subunit vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Inactivated vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Nucleic acid based vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Dengue Vaccines Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global NGO’s Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Government Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pharmacy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Dengue Vaccines Market Value, 2018 – 2028, (US$ Mn)